CohBar, Inc. (NASDAQ:CWBR – Get Free Report) traded up 4.7% during mid-day trading on Monday . The stock traded as high as $0.51 and last traded at $0.51. 155 shares traded hands during trading, a decline of 93% from the average session volume of 2,369 shares. The stock had previously closed at $0.49.
CohBar Trading Up 4.7 %
The firm’s fifty day moving average is $0.49 and its 200-day moving average is $0.53.
CohBar Company Profile
CohBar, Inc, a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases.
Read More
- Five stocks we like better than CohBar
- Profitably Trade Stocks at 52-Week Highs
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Applied Materials Market Capitulates: Now is the Time to Buy
- The Most Important Warren Buffett Stock for Investors: His Own
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for CohBar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CohBar and related companies with MarketBeat.com's FREE daily email newsletter.
